Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.

Bechini A, Levi M, Boccalini S, Tiscione E, Ceccherini V, Taddei C, Balocchini E, Bonanni P.

J Prev Med Hyg. 2012 Jun;53(2):61-7.

PMID:
23240162
2.

Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.

Bechini A, Levi M, Boccalini S, Tiscione E, Balocchini E, Canessa C, Azzari C, Bonanni P.

Vaccine. 2012 Oct 5;30(45):6396-401. doi: 10.1016/j.vaccine.2012.08.019. Epub 2012 Aug 23.

PMID:
22921931
4.

Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series.

de Waure C, Miglietta A, Nedovic D, Mereu G, Ricciardi W.

Hum Vaccin Immunother. 2016;12(2):467-73. doi: 10.1080/21645515.2015.1078951.

5.

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team.

Vaccine. 2001 Aug 14;19(31):4566-75.

PMID:
11483285
6.

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.

Caro JJ, Möller J, Getsios D, Coudeville L, El-Hadi W, Chevat C, Nguyen VH, Caro I.

BMC Public Health. 2007 Jun 29;7:130.

7.

Evolving meningococcal immunization strategies.

Sáfadi MA, Bettinger JA, Maturana GM, Enwere G, Borrow R; Global Meningococcal Initiative.

Expert Rev Vaccines. 2015 Apr;14(4):505-17. doi: 10.1586/14760584.2015.979799. Epub 2014 Dec 10. Review.

PMID:
25494168
8.

Meningococcal C vaccines: the Canadian experience.

De Wals P.

Pediatr Infect Dis J. 2004 Dec;23(12 Suppl):S280-4.

PMID:
15597070
9.
10.
11.

Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.

Vickers DM, Anonychuk AM, De Wals P, Demarteau N, Bauch CT.

Vaccine. 2015 Jan 1;33(1):268-75. doi: 10.1016/j.vaccine.2013.09.034. Epub 2013 Oct 6.

12.

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.

Arnold R, Galloway Y, McNicholas A, O'Hallahan J.

Vaccine. 2011 Sep 16;29(40):7100-6. doi: 10.1016/j.vaccine.2011.06.120. Epub 2011 Jul 29.

PMID:
21803101
13.

Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.

Pereiró I, Díez-Domingo J, Morant A, Gimeno C, Lerma M, San-Martín M, González A; Group for the Study of Invasive Diseases.

Scand J Infect Dis. 2001;33(8):581-4.

PMID:
11525350
14.

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.

Tauil Mde C, Carvalho CS, Vieira AC, Waldman EA.

Braz J Infect Dis. 2014 Jul-Aug;18(4):379-86. doi: 10.1016/j.bjid.2013.11.012. Epub 2014 Mar 31.

15.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
16.

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.

Sáfadi MA, McIntosh ED.

Expert Rev Vaccines. 2011 Dec;10(12):1717-30. doi: 10.1586/erv.11.159. Review.

PMID:
22085175
17.

Meningococcal conjugate vaccines: efficacy and new combinations.

Sáfadi MA, Barros AP.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S35-44. Review.

18.

Optimizing protection against meningococcal disease.

Reisinger KS, Black S, Stoddard JJ.

Clin Pediatr (Phila). 2010 Jun;49(6):586-97. doi: 10.1177/0009922809354327. Epub 2010 Jan 20. Review.

PMID:
20089551
19.

Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.

Garrido-Estepa M, León-Gómez I, Herruzo R, Cano R.

Vaccine. 2014 May 7;32(22):2604-9. doi: 10.1016/j.vaccine.2014.03.010. Epub 2014 Mar 21.

PMID:
24662700
20.

Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme.

Lawrence GL, Wang H, Lahra M, Booy R, McINTYRE PB.

Epidemiol Infect. 2016 Aug;144(11):2382-91. doi: 10.1017/S0950268816000704. Epub 2016 Apr 20.

PMID:
27094814

Supplemental Content

Support Center